2 rezilta yo
FIELD OF THE INVENTION
The present invention relates generally to novel herpes simplex virus glycoprotein D molecules. More particularly, the present invention relates to variant glycoprotein D molecules which are capable of blocking infection of cells by herpes simplex virus.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates generally to novel herpes simplex virus glycoprotein D molecules. More particularly, the present invention relates to variant glycoprotein D molecules which are capable of blocking infection of cells by herpes simplex virus.
BACKGROUND OF THE